Nucleic acid encoding melanin-concentrating hormone receptor
US7198910B1 · kind B1 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 10, 2000 |
| Grant date | Apr 3, 2007 |
| Priority date | — |
| Expiry date | May 9, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application features two different forms of the human MCH receptor: (1) MCH-R2 and (2) MCH-R3. Such MCH receptors provide a target for achieving a beneficial affect in a patient and facilitate the screening of compounds that modulate MCH receptor activity or expression. Beneficial effects that can be obtained include increasing appetite, decreasing appetite, and reducing stress.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.